Since 2020, HRSA has posted hundreds of manufacturer notices affecting covered entities, while litigation involving contract-pharmacy restrictions and state protections continues to reshape the program.
For community health centers, the risk is not simply that 340B is changing. It is that these changes can affect cash flow, financial performance, compliance, and patient services before leadership understands the full impact.
A manufacturer notice may initially appear to be a pharmacy issue. In practice, it can change which prescriptions qualify, how inventory is replenished, what data must be submitted, when savings are realized, and whether anticipated 340B value ever reaches the health center.
That makes 340B a leadership priority.
FIRST: A health center can be compliant—and still miss opportunities
Traditional 340B oversight often focuses on audit readiness, diversion, duplicate discounts, and documentation. These controls are critical, but compliance alone does not reveal the program’s full performance.
A focused assessment should determine whether:
- Policies reflect actual workflows
- Internal controls are operating effectively
- Eligible prescriptions are being captured
- Expected financial value is being reconciled
- Pharmacy relationships are performing as anticipated
- Opportunities exist to responsibly strengthen the program
A health center can pass an audit while still losing value—or generate value while carrying risks leadership cannot see.
SECOND: Stop reporting savings without reporting exposure
A report showing total 340B savings tells only part of the story. Leadership also needs a monthly view of:
- Budget-to-actual performance
- Expected versus realized value
- Uncaptured eligible claims
- Outstanding and aging payments
- Financial value tied to unresolved exceptions
- Open changes and corrective-action deadlines
The critical measure may be 340B value at risk: the dollars connected to unresolved financial, operational, data, or compliance issues.
THIRD: Build a practical, technology-enabled management system
Health centers can begin with three connected tools:
- A change tracker that converts every material development into an assigned action
- A monthly financial report that shows performance, variance, and dollars at risk
- A budget and forecasting tool that projects the potential year-end impact
Technology can then automate monitoring, reconciliation, exception identification, financial tracking, and escalation. The objective is not another labor-intensive dashboard. It is a management system that directs staff and leadership to the decisions and actions requiring attention.
The takeaway
340B oversight should answer five questions:
What changed? Where are the gaps? What dollars are at risk? What opportunities are we missing? What action is required? Community health centers depend on 340B to sustain services and continue their mission. Protecting that value requires more than reacting to the next announcement.
How We Can Help
COPE Health Solutions can help evaluate your program’s compliance, operational weaknesses, financial gaps, and growth opportunities—and connect the findings to practical, technology-enabled solutions designed to help your 340B program reach its full potential. Contact us to get started.
Karen Kinter is an experienced healthcare executive and consultant with extensive expertise supporting federally qualified health centers and hospital systems. Her work focuses on strengthening 340B program compliance, identifying financial and operational opportunities, and developing sustainable strategies that help healthcare organizations maximize program value while advancing their missions.